Abstract
High salt diet (HSD) has deleterious effects on the vasculature by mechanisms not fully elucidated. We demonstrated tight coupling between Na + and Ca 2+ levels in VSMCs, where PARP-regulated TRPM2, a redox-sensitive Ca 2+ channel, plays an important role. Increased [Ca 2+ ]i also contributes to inflammasome assembly, which dysregulates vascular function. We hypothesized that HSD induces a pro-oxidant environment that contributes to PARP-induced TRPM2-activation, Ca 2+ influx and inflammasome assembly, leading to vascular damage. WKY rats were treated with 1% HSD (3 weeks). Blood pressure was assessed by tail-cuff methodology, vascular reactivity was assessed in mesenteric arteries and calcium influx, ROS generation, inflammasome and pro-contractile marker in vascular smooth muscle cells (VSMCs) in presence and absence of HS medium (HSM-140mM). HSD did not increase blood pressure (BP), but vascular contractility was exaggerated (Emax(mN): WT 10.20 ± 0.70 vs 15.17 ± 1.74), effect reversed by PARP (Emax: 11.14 ± 1.24) and TRPM2 (8-br) (Emax: 11.45 ± 1.11) inhibitors. In VSMCs, HSM behaves as a pro-oxidant agent (ROS-AU: Control 77.51 ± 2.80 vs 130.04 ± 13.89 HSM), leading to increased [Ca 2+ ]i (AUC: Control 25562.45 ± 880.48 vs 30924.8 ± 1263.85 HSM) and activation of myosin light chain (pMLC-AU: Control 99.27 ± 1.01 vs 626.87 ±71.28 HSM), by mechanisms dependent on ROS and PARP/TRPM2 activation. HSM also increased expression of inflammasome components NLRP3 (2 ΔΔCt : Control 1.20 ± 0.01 vs 1.85 ± 0.19 HSM), ASC (2 ΔΔCt : Control 1.02 ± 0.01 vs 1.49 ± 0.17 HSM) and Caspase 1 (2 ΔΔCt : Control 1.06 ± 0.03 vs 2.35 ± 0.46 HSM), which was prevented by ROS scavenger Tiron and PARP inhibitor. In conclusion, HSD-induced vascular hypercontractility involves ROS activation of PARP/TRPM2 signalling. Activation of PARP/TRPM2 was associated with increased [Ca 2+ ]i and activation of pro-contractile signaling and inflammasome assembly. Normal BP in HSD-fed rats in the presence of vascular damage suggests that ROS/PARP/TRPM2 signaling induced by salt influences vascular function independently of BP elevation. We identify a novel pathway that underlies salt-induced vascular damage and suggest a potential therapeutic role for PARP/TRPM2 inhibitors in vascular dysfunction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.